(1 point) A new chemotherapy regime for the treatment of ovarian cancer consisti
ID: 3341212 • Letter: #
Question
(1 point) A new chemotherapy regime for the treatment of ovarian cancer consisting of a combination of gemcitabine and cisplatin, or GEMCIS, is to be treated on women with Stage lll ovarian cancer. The null hypothesis is that the GEMCIS treatment is not more effective than the current treatment protocol, one that only uses cisplatin. In the context of a hypothesis test (a) select the correct explaination of a Type I error O A. One would conclude that GEMCIS is a more effective treatment of ovarian cancer than the current treatment protocol, when in fact GEMCIS is not more effective than the current treatment protocol B. One would conclude that GEMCIS is not a more effective treatment of ovarian cancer than the current treatment protocol, when in fact GEMCIS is more effective than the current treatment protocol O C. One would conclude that GEMCIS is not a more effective treatment of ovarian cancer than the current treatment protocol, when in fact GEMCIS is not effective than the current treatment protocol O D. One would conclude that GEMCIS is a more effective treatment of ovarian cancer than the current treatment protocol, when in fact GEMCIS is more effective than the current treatment protocol (b) select the correct explaination of a lype ll error O A. One would conclude that GEMCIS is not a more effective treatment of ovarian cancer than the current treatment protocol, when in fact GEMCIS is not more effective than the current treatment protocol O B. One would conclude that GEMCIS is a more effective treatment of ovarian cancer than the current treatment protocol, when in fact GEMCIS is not more effective than the current treatment protocol O C. One would conclude that GEMCIS is a more effective treatment of ovarian cancer than the current treatment protocol, when in fact GEMCIS is more effective than the current treatment protocol O D. One would conclude that GEMCIS is not a more effective treatment of ovarian cancer than the current treatment protocol, when in fact GEMCIS is more effective than the current treatment protocolExplanation / Answer
We know that
Type 1 error is when we reject the null hypothesis when we should not
This means in context , we reject null in favor of alternate hypothesis and conclude that
Once would conclude that GEMCIS is more effective treatment of ovarian cancer than the current treatment protocal , when in fact gemcis is not more effective .
Hence A
Type 2 error is when we accept null hypothesis when we should not
Hence D
Once would conclude that GEMCIS is not more effective treatment of ovarian cancer than the current treatment protocal , when in fact gemcis is more effective
Hope this helps !!
Related Questions
Navigate
Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.